

Cytochrome-C is a natural enzyme preparation from the group of antihypoxic and metabolic agents. Cytochrome C has an antihypoxic, trophic effect, stimulates regeneration processes.
Cytochrome C is an enzyme involved in tissue respiration (it is a catalyst for cellular respiration).
Cytochrome C is used in cardiology practice in the case of myocardial infarction, leading to rapid recovery of patients. Cytochrome C has proven itself as a prophylactic agent for liver and cardiovascular diseases.
Viral hepatitis, asphyxia (including newborns), pneumonia, asthmatic conditions, coronary heart disease, senile retinal degeneration, intoxication.
Cytochrome C - 10 mg.
Excipients: sodium chloride.
No customer reviews for the moment.
The drug is used intravenously and intramuscularly. Before using Cytochrome-C, the contents of the vial should be dissolved in 4 ml of water for injection and determine the individual sensitivity to it. For this purpose, 0.1 ml of the drug (0.25 mg) is injected intradermally. If a reaction does not occur within 30 minutes (reddening of the face, itchy skin, urticaria), then the treatment can be started. Before the appointment of a repeated course must repeat a biological sample.
The drug is administered intravenously slowly or intramuscularly in an amount of 10-20 mg 1-2 times a day. The course of treatment is 10-14 days.
For heart failure, the drug is diluted in 200 ml of isotonic solution of sodium chloride or 5% glucose solution and administered intravenously (30-40 drops per minute) for 6-8 hours. The daily dose is 30-80 mg.
In the postoperative period (surgery for congenital and acquired heart defects), the drug is administered intravenously 2 times a day, 10 mg per injection. In case of a serious condition (trauma, shock, hepatic coma, poisoning with hypnotic drugs and carbon monoxide), the drug is prescribed in an amount of 50-100 mg. With asphyxia of the newborn, the drug is administered into the umbilical vein during the first two minutes after birth at a dose of 10 mg.
In case of bronchial asthma, the drug is administered intramuscularly 2 times a day at a dose of 5-10 mg per injection. The course of treatment lasts from 14 to 25 days, depending on the severity of hypoxia.
Chills, hyperthermia (with the rapid introduction into the vein).
Individual intolerance to the components of the drug.
Not described.